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In the 250 years since the Swedish
scientist Carl Linnaeus first started classi-
fying organisms, taxonomists have formal-
ly described roughly 1.7 million species.
Although seemingly large, this number
represents only a small fraction of the
estimated tens of millions of species on the
planet. Moreover, human activities are
causing the extinction of species hundreds
of times faster than the natural rate of
extinction found in the fossil record. Fully
one-third of all species on the planet may
be gone by the end of this century—many
without ever having been studied or, more
importantly, protected [1].
DNA barcoding, developed in 2003 to
identify species, has helped to rejuvenate
taxonomic research. The science of tax-
onomy is key to understanding and
monitoring biodiversity [2]. The tech-
nique is based on a simple but powerful
observation: that sequence diversity, in
short, standardized gene regions (i.e.,
DNA barcodes), can serve as a tool to
identify known species and potentially
discover new ones. Moreover, DNA
barcoding allows researchers to develop
a system for species identification based
on digital characters, eventually allowing
for automated identifications, thereby
promising to improve the capacity to
identify, monitor, and manage biodiversi-
ty, with profound societal and economic
benefits. It also raises the possibility of
identifying the vectors of zoonotic diseases
as well as the disease organisms them-
selves.
Using DNA barcoding technology, re-
searchers seek to build a library of short,
standardized pieces of DNA from all of
Earth’s species—an admittedly massive
undertaking that would enable the scien-
tific community to quickly and accurately
assess the Earth’s biodiversity and monitor
it over time [3]. The promise of this
technology has captured the attention of
the scientific community, government
agencies, and the general public. Wide-
spread support has led to nearly US$100
million in grants that have been used to
mobilize a large research program in DNA
barcoding and establish the Consortium
for the Barcode of Life (CBOL; http://
www.barcoding.si.edu), with 200 member
organizations in 50 countries. A national
research network in Canada has directed
its efforts towards simplifying the protocols
for DNA barcode acquisition, gathering
barcode records, and developing the
informatics platform needed for the cura-
tion and analysis of barcode records. The
latter effort has led to the creation of
BOLD, the Barcode of Life Data Systems
(http://www.boldsystems.org), which now
has more than 5,000 registered users and
holds barcode records for more than
850,000 specimens, representing approxi-
mately 100,000 species. Individual organ-
isms are placed in museum collections,
and their extracted DNA resides in a
secure repository, so that future genera-
tions can study them.
To coordinate these global efforts, an
alliance of researchers and biodiversity
conservation organizations plan to launch
the International Barcode of Life Project
(iBOL; http://www.ibolproject.org) in
October 2010 the International Year of
Biodiversity. The project will bring togeth-
er 26 countries to broaden and strengthen
DNA barcoding research with potential
social, cultural, and economic, implica-
tions—direct and indirect—with a special
focus on developing countries. Because the
true stewards of biological diversity are at
the local level, it is imperative that they be
included in the process. This means
obtaining consent from the competent
authority before collecting specimens and
barcoding, sharing the resulting data with
local people, and building capacity to use
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appears to fall under the scope of ‘‘access
to genetic resources and the fair and
equitable sharing of benefits’’ in the
Convention on Biological Diversity. Bar-
coders must disclose up-front foreseeable
consequences of their research (both
intended and unintended) so that govern-
ments at national and state levels can
develop informed policies.
To date, researchers in developed
countries have largely performed DNA
barcoding, even though most of the
Earth’s biodiversity is found in the
tropical and subtropical regions. The
iBOL aims to rectify this situation by
collaborating with researchers and local
communities in developing countries to
retrieve DNA barcodes from 5 million
specimens representing 500,000 of
Earth’s species within the first five years
of its operations. Work will focus on
taxonomic groups targeted for analysis by
iBOL because they deliver key ecosystem
services (e.g., pollinators), because they
are pests (e.g., termites), because they are
harvested (e.g., fishes, forest trees), or
because they are important targets for
conservation programs (e.g., mammals,
reptiles). A number of teams in develop-
ing countries will deploy scientific exper-
tise and the built-up barcode library to
apply barcoding as a tool for environ-
mental or ecosystem management.
Building Partnerships
Because many developing countries
lack the resources and scientific capacity
Box 1. The Convention on Biological Diversity: Access and Benefit Sharing Principles in the Context of
Barcoded Genetic Information, by Manuel Ruiz Muller (Director of the International Affairs and
Biodiversity program of the Peruvian Society for Environmental Law, Lima, Peru) [6]
Since 1993, the year when the Convention on Biological Diversity (CBD) entered into force, the ‘‘common heritage of mankind’’
principle has given way to the recognition of sovereignty over genetic resources. Laws and regulations now affirm state rights over
genetic resources and seek to establish legal regimes based on access to genetic resources and the fair and equitable sharing of
benefits (ABS). These legal frameworks cover mostly animal, plant, and microbial genetic resources as defined by the CBD.
Parallel advances in modern biotechnology (e.g.,cloning) and whole new disciplines—genetic engineering,genomics, proteomics—
have radically transformed research and development processes. Yet, these technologies and new scientific disciplines are largely
unaccounted for in policy and legal debates concerning ABS. Barcoding is exemplary of this phenomenon.
The CBD defines genetic resources very broadly as ‘‘genetic material of actual or potential value’’ and genetic material as ‘‘any
material of plant, animal, microbial, or other origin containing functional units of heredity.’’ This ‘‘potential value’’ is rapidly
being realized in many fields, including pharmaceuticals, medicine, and plant-breeding.
Gene libraries and rich, sophisticated databases are transforming the way scientists undertake routine research. For example,
anyone with the requisite scientific skills, a good laptop computer and a reliable Internet connection, can easily access, screen,
and transform genetic information into potentially useful innovations. Indeed, new theories, tools, and technologies are
changing the way biological classification takes place. As soon as DNA or genes are involved, that is ‘‘the functional units of
heredity,’’ the CBD ABS policy and legal principles become relevant.
Seeking a balance between private rights and sovereignty is one of the driving forces behind CBD policy and legal
developments, as evidenced in access legislation and defensive protection measures, including the protection of traditional
knowledge. In each case, the nature and timing of benefits will depend on the policies and regulations set by states, and
agreements reached between states, researchers, companies, and indigenous people.
To date, the seemingly endless debate about ABS in the CBD eclipses an often overlooked set of provisions of the CBD that refers to
conservation per se and the need to understand biodiversity dynamics and species at the ecosystem level. Taxonomy, in this regard,
is a critical discipline that serves conservation and may also play an important role in profit, commercial, or industrial endeavours.
Encouragingly, one notes that members of iBOL ‘‘…are committed to the regulatory framework established under the CBD’’
and expressly indicate that ‘‘transactions between iBOL members will respect all restrictions with respect to biomaterials
transfers.’’ However, it is far from clear what exactly this commitment means and how it will be put into practice. A global
project of this magnitude should reflect upon the potential social, cultural, and economic, implications—direct and indirect—of
its activities, particularly on developing countries. The main concern is whether and how CBD principles are pertinent or even
relevant to work and activities undertaken by iBOL. Here is a preliminary list of questions for the stakeholders in iBOL:
N Do ABS principles apply to iBOL activities?
N How will developing countries participate in iBOL?
N Do iBOL activities affect national sovereignty of countries of origin?
N Is the sovereignty of countries of origin being affected when genetic resources are accessed from Barcode of Life databases?
N How might the cultural rights of indigenous people be affected by iBOL?
N What benefits can be shared with countries of origin?
N How with those benefits be shared?
N And, lastly, are commercially or industrially oriented uses of iBOL services and products envisioned? If so, are there limitations,
guidelines or other orienting principles?
Because a diversity of opinions will emerge in response to the above questions, negotiation appears to be paramount.
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developed a tiered participation structure
to enhance inclusiveness. It consists of
national, regional, and central nodes.
iBOL will bolster scientific capacity by
providing the funding necessary to train
young scientists. In addition, it will
broaden exposure to barcode technology
by delivering training sessions and by
launching projects that validate the
practical implications of barcode tech-
nology. The database of Earth’s biodi-
versity arising from iBOL will be free for
the world to access and use. Inasmuch as
commercial applications may arise from
barcoding technologies and their use,
iBOL is committed to ensuring that
citizens of all nations have an equal
chance to take advantage of any oppor-
tunity [4]. iBOL adheres to the three
main objectives of the Convention on
Biological Diversity (CBD): conservation
of biodiversity; sustainable use of biodi-
versity; and the fair and equitable
sharing of the benefits arising from the
use of genetic resources.
There are many benefits to iBOL
participation for capacity building at a
national level in countries that harbor
much of the biodiversity that barcoders
are interested in, such as the training of
students in state-of-the-art field collec-
tion and laboratory techniques and the
development of basic science. Neverthe-
less, history is filled with countless
examples of other scientific projects
where—even with the best of inten-
tions—benefits derived from biological
materials were never shared with the
countries of origin. Governments of
developing countries are understandably
skeptical of scientific endeavors originat-
ing from the developed countries, some-
times resulting in strict laws—as in
India—where foreign access to biological
materials is all but impossible.
Perhaps because iBOL and barcoding
a r em o r ed r i v e nb yn a t u r a ls c i e n t i s t s ,
m o s tb a r c o d e r sh a v et h u sf a rt a k e na
rather naive stance on issues of access
and benefit sharing (ABS) that belong
more to the spheres of policy and law.
Where difficulties have been encoun-
tered in obtaining specimens from cer-
tain countries with strict biodiversity
export rules (e.g., Brazil and India),
barcode projects have been delayed or
limited to small-scale efforts. However,
iBOL recognizes that such a strategy is
not sustainable as the endeavor continues
to grow. For this reason, iBOL together
with CBOL asked experts at a recent
conference (http://www.dnabarcodes2009.
org/) to draft position papers about access
and benefit sharing as they relate to the
iBOL project. Summaries of three key
perspectives, relating barcoding to the
Convention on Biological Diversity, eco-
nomics, and the sociological implications in
one region are provided in Boxes 1–3,
respectively. They serve to illustrate the
complexity and contention surrounding
some of the major issues involved. The
three presentations from the Third Interna-
tionalBarcodeofLifeConferenceinMexico
City, November 2009, arefreelyavailableas
video through the iBOL site at http://
vimeo.com/user2807308.
Box 2. iBOL as an Enabler of ABS and ABS as an Enabler of iBOL,b y
Joseph Henry Vogel (Professor of Economics, University of
Puerto Rico-Rı ´o Piedras, USA) [6]
‘‘Thinking like an economist’’ is the mantra of my profession and I cringe
whenever I hear it. I count myself among the dissidents who believe that
‘‘thinking like an economist’’ has enabled the destruction of biological
communities, both human and non-human [7]. Nevertheless, I would be the
first to say ‘‘let’s not throw the baby out with the bathwater.’’ Much of the
discussion about the iBOL proceeds as if formal economics did not exist. Since the
ratification of the United Nations Convention on Biological Diversity (CBD) in
1993, I have grown inured to the lack of any economic thinking when the
Conference of the Parties (COP) meets to discuss access and benefit sharing (ABS)
[8]. Insisting on thinking like an economist, I hope to show that a baby can still
emerge from the confluence of ABS and iBOL.
Ever since Adam Smith, economics has been associated with selfish interests. How
do we align the interests of industry which researches and develops genetic
resources with those of countries which decide the fate of those resources? [9]
The answer from the CBD is S-O-V-E-R-E-I-G-N-T-Y. Various articles overturn ‘‘the
common heritage of mankind’’ and allow countries to negotiate bilaterally. Who
could object? I did and let me explain by way of an analogy [10].
In the streets of the developing world, a thriving market exists in pirated movies.
The hawker typically asks $1 per DVD which is 5% of the retail price. Why not $19,
$18…or even $2? The answer is competition. Each hawker underbids other
hawkers and the price falls to the marginal costs of hawking. No monopoly rent is
ever paid to the creator of the artificial information, namely, Hollywood.
The same holds true for natural information. When reported, royalties are typically
1% or less. Most metabolites are diffused across species and species, across
political boundaries. Each country underbids other countries and ABS falls to the
marginal costs of consummating a Material Transfer Agreement (MTA). No rent is
ever paid to the conservationist of natural information—the countries of origin.
Thinking like an economist, the only way to capture a rent (e.g., 15%) is through
the cartelization of genetic resources [11].
How much would each country get? A simple solution is a share proportional to
the habitat. If Brazil occupies 56% of the Amazon and Ecuador, 2%, the former
would get 56% of the royalty and the latter, 2% for a metabolite distributed
throughout the basin. Cartelization with a concomitant disclosure requirement of
species in patent applications would obviate MTAs and allow the free flow of
genetic resources.
iBOL can become the enabler for ABS but does ABS enable iBOL? The answer is
money. Many metabolites are so widely distributed that the cumulative costs of
determining each country’s fair share would outstrip the sum collected. In such
cases, the royalties ‘‘should be used to diminish the fixed costs of the gargantuan
database’’ [12]. I penned those words in 1992 long before I imagined that iBOL
would emerge as a gargantuan database.
Will iBOL support a biodiversity cartel in the ongoing COP discussions about an
‘‘International Regime on ABS?’’ I am hopeful, not because I believe that iBOL will
do the right thing—people seldom do. My reason for hope is that doing the right
thing behooves iBOL, materially so. Adam Smith’s most famous phrase about the
butcher, the brewer and the baker, is still apt. It will not be from the benevolence
of iBOL that iBOL enables fair and equitable ABS, but from regard to its own
interest. Now, what could be more economic in thinking than that?
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Diversity defines genetic resources ‘‘as genetic
material of actual or potential value,’’ where
genetic material means ‘‘any plant, animal,
microbial, or other origin containing func-
tional units of heredity.’’ Yet, the genetic
material in food, fibers, and extracts—
containing functional units of heredity—flow
freely across borders while well-meaning
scientific endeavors are blocked.
The interpretation of the definition of
genetic resources is still an area of active
debate within the negotiations of the
International Regime on access and ben-
efit sharing under the CBD, which is to be
adopted at the 10th meeting of the
Conference of the Parties, in October
2010, in Japan [5]. iBOL must attempt to
influence that debate to ensure a set of
recommendations that protects biodiversi-
ty-rich nations while simultaneously avoid-
ing the inhibition of scientific progress.
Recognizing that the road ahead will
not be smooth as access and benefit
sharing issues remain highly contentious,
there are steps that iBOL can take to
ensure that roadblocks are minimized:
N First and foremost, DNA barcoding
needs to be recognized as non-com-
mercial research, like most of taxono-
my. It offers significant non-monetary
benefits that will be shared openly with
countries that provide access to their
biodiversity by participating in iBOL.
N Second, it is necessary to formalize
what it means for a nation to partic-
ipate in iBOL. ABS concerns must be
clearly laid out and guidelines for the
commercial or industrial use of iBOL-
related products and services should be
established.
N To the extent possible, iBOL must
determine from the outset foreseeable
consequences of the project (both
intended and unintended) so that
governments can develop informed
policies.
N Finally, although it is critical to engage
national and state governments, the
true stewards of biological diversity lie
at the local level and must be included
in the process. This not only means
obtaining consent from the competent
authority before collection and DNA
barcoding, but also sharing the result-
ing data with local communities and
training them in its use.
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Box 3. DNA Barcoding: Society and technology dynamics in the Indian
context, by Ejnavarzala Haribabu (Professor of Sociology,
University of Hyderabad, India) [6]
India is a ‘‘mega hot spot’’ of biodiversity. A culture of conservation has emerged
over the years as part of a utilitarian and aesthetic value system where
households and communities conserve the germplasm of crop and medicinal
plants as well as horticulture and some species of animals in situ. In the absence
of written rules, the conservation and use of biodiversity have been traditionally
regulated by religious norms and sanctions. Over time, communities acquired
empirical knowledge about the utility of various plant species and animals and
developed local taxonomies that they share.
The Plant Varieties and Farmers’ Rights Act in 2001 and the National Biological
Diversity Act in 2002 gave effect to the CBD in the Indian context and now
govern ABS issues. The National Biological Diversity Act (NBDA) does not allow
foreign nationals and non-resident Indians to carry out biodiversity research or
develop and access genetic resources without prior permission of the National
Biodiversity Authority (NBA). No person can apply for any intellectual property
right in or outside India for any invention based on any research or information
on a biological resource obtained from India without obtaining the prior
approval of the NBA. The Authority may impose a benefit sharing fee or a
royalty, or both. However, the recent amendment of the Act notified through
the Gazette of India by the Ministry of Environment and Forests on November 8,
2006, allows access to biodiversity for collaborative projects in the area of
taxonomic studies subject to the approval of concerned Departments/Ministries
of the Government of India.
Any attempt to barcode species for research purposes—whether commercial
or not—requires the prior informed consent of the custodians or stewards. The
normative basis of terms of consent differs in the two situations. As of this
writing, the Act seems to emphasise access and benefit sharing in the context
of commercial research. Nevertheless, a series of questions regarding non-
commercial research typical of iBOL arises: what are the norms that should
govern access that (a) promotes non-commercial research, (b) protects the
national sovereignty over genetic resources, and (c) ensures non-monetary
benefits, if any? Schindel et al. [4] point out the tangible indicators of
distinguishing non-commercial research from commercial research [13]. These
include the generation of new knowledge, the collection of reference
specimens in the public domain, and capacity building, particularly in
developing countries. Regarding the latter, one can say that in India there
are qualified and competent scientists and well endowed molecular biology
research institutions.
Because the Act regulates access to commercial research, there is a need to
examine whether or not the existing provisions and the recent amendments
made to the provisions of the Act, are adequate to ensure that the genetic
resources accessed for non-commercial research are not used for commercial
research at a later date, and are not shared with a third party. Further, norms
for material transfer agreements must protect national interests; and
communities should participate in negotiations regarding access and
benefit-sharing.
As a part of this process of democratization of barcoding technology, efforts
should be made to seek the consent of local communities and build their
capacities to use barcoded information for monitoring and developing
biodiversity. Communities should be informed about the benefits of barcoding
and take part in decisions regarding what species are to be barcoded.
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